| Identification | Back Directory | [Name]
Zanidatamab | [CAS]
2169946-15-8 | [Synonyms]
Zanidatamab
Research Grade Zanidatamab
Research Grade Zanidatamab (DHC09607) |
| Hazard Information | Back Directory | [Uses]
Zanidatamab (ZW25) is a humanised, bispecific monoclonal antibody targeting 2 distinct HER2 epitopes (ECD2 and ECD4). Zanidatamab has anti-tumour activity[1]. | [in vivo]
Zanidatamab (ZW25) induces significant tumor regressions, exhibiting 307% tumor growth inhibition relative to hIgG control and a 70% complete regression rate[1]. | [IC 50]
HER2 | [References]
[1] Weisser N, et, al. Preclinical development of a novel biparatopic HER2 antibody with activity in low to high HER2 expressing cancers. Cancer Res. 2017:77 (13). |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
|